Novo Nordisk Foundation Center for Basic Metabolic Research > News > 2017 > Scientific Director Je...
24 March 2017
Scientific Director Jens Juul Holst receives the Harrington Prize for Innovation in Medicine
His discovery of the GLP-1 hormone and translation of these results into new treatments for widespread metabolic diseases like diabetes is the reason why Professor Jens Juul Holst receives the 2017 Harrington Prize for Innovation in Medicine. The prize was established in 2014 by the Harrington Discovery Institute at University Hospitals in Cleveland, Ohio and the American Society for Clinical Investigation (ASCI), and it honours scientists who have moved science forwards through innovative discoveries with potential for clinical application.